Huoxue Jiangzhuo Capsule In The Clinical Study Of Regulating Phlegm And Blood Stasis Resistance Type Dyslipidemia

Objective: Through observation of blood circulation and descending the turbid Capsule on blood lipid abnormality(belonging to Chinese medicine phlegm and blood stasis type) of blood lipid in patients with four, blood rheology, the change of TCM syndrome integral, of Huoxue Jiangzhuo capsule regulating dyslipidemia(stagnation of phlegm and blood stasis) the safety and effectiveness of make a preliminary evaluation.Methods: A randomized, positive drug parallel comparison method, the choice conforms to the 120 cases of patients with dyslipidemia in western medicine diagnosis and syndrome differentiation of TCM phlegm and blood stasis, were randomly assigned to two groups, the case ratio is 1:1. 60 cases in the treatment group, 60 cases in the control group. Dosing regimen: in treatment group were treated with activating blood circulation and descending turbid capsule, 4 capsules each time, 3 times a day; control group oral lipid will Tai capsule, one pill each time, 2 times a day; 8 weeks for a course of treatment. Treatment were compared between the two groups at the end of the blood lipid, blood rheology, changes of TCM syndrome integral, TCM syndrome curative effect.Results: Blood fats curative effect evaluation: treatment group total effective rate was 85.7%; in the control group, the total effective rate was 83.3%, between the two groups compared with statistical significance(P < 0.05), treatment group curative effect surpasses the control group. 2 TCM efficacy evaluation: treatment group total efficiency was 96.4%; in the control group, the total effective rate was 81.5%, between the two groups compared with statistical significance(P < 0.05), treatment group curative effect surpasses the control group. 3 single symptom curative effect evaluation: head such as wrap, stuffy chest expansion, vertigo symptom curative effect between the two groups compared with statistical significance(P < 0.05) treatment group curative effect surpasses the control Group. And vomiting phlegm, body fat between the groups compared the difference was not statistically significant(P > 0.05). Total cholesterol(4) after the treatment, the value of whole blood viscosity at high shear rate, plasma viscosity were compared with statistical significance(P < 0.05), and other indexes between the groups no difference statistically significant(P > 0.05). The two groups did not occur adverse reactions and safety examination no abnormalities.Conclusion: Clinical trial results confirm: Huoxue Jiangzhuo capsule by adjusting dyslipidemia patients of blood rheology and blood lipids level, alleviate the patients’ clinical symptoms. And activating blood circulation and descending turbid capsule in regulating blood fat abnormality(type of phlegm and blood stasis) is safe and effective, non-toxic side effects.